NCT07131943

Brief Summary

The purpose of the current study is to: Compare between radiofrequency (TECAR) therapy and ultrasound on Shoulder Pain, Range of Motion and Functional Outcome in Patients with stroke.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 13, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 20, 2025

Completed
1 month until next milestone

Study Start

First participant enrolled

September 28, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 12, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 12, 2025

Completed
Last Updated

October 2, 2025

Status Verified

September 1, 2025

Enrollment Period

2 months

First QC Date

August 13, 2025

Last Update Submit

September 28, 2025

Conditions

Keywords

StrokeHemiplegiaTECARRadiofrequencyShoulder Pain

Outcome Measures

Primary Outcomes (4)

  • Digital Goniometer for shoulder range of motion

    The digital goniometer (Baseline 12-1027 USA) will be used to assess range of motion (ROM) of the shoulder joint. The device consists of fixed arm, movable arm and screen. The device converts the angular displacement of the joint (represented in the degree of change of the angle between the two arms of the device) into an electric signal readout which is produced in a simple digital form. The device is the most accurate and objective method of ROM measurement with excellent inter-rater and intra-rater ranged from 0.89 to 0.98

    4 Weeks

  • The pressure algometer

    The pressure algometer, specifically the hand-held Baseline® model, is a reliable and valid tool used to objectively measure pressure pain thresholds (PPT). It features a pistol-style grip and a pressure-sensitive gauge with a 0.785 cm² rubber tip. The device applies gradual, consistent manual force to determine the minimal pressure at which a sensation of pressure turns into pain. This method is widely used in clinical settings due to its strong correlation with pain intensity and excellent inter-rater reliability, making it a dependable tool for assessing pain sensitivity.

    4 weeks

  • Numerical Rating Scale (NRS):

    Numerical Rating Scale (NRS): For pain Threshold will be assessed by Numeric pain rating scale (NPRS) is an 11-point (0-10) Scale will be used to measure pain. Patients verbally will select value between (0-10) based on intensity of pain. (0) means No pain and (10) means maximum pain experienced at baseline

    4 weeks

  • Functional Outcome and disability / Shoulder pain and Disability Index (SPADI)

    The Shoulder Pain and Disability Index (SPADI) is a 13-item questionnaire used to assess the intensity of shoulder pain and the degree of functional disability. It includes two subscales: five questions evaluating pain severity and eight questions assessing difficulty with daily activities involving upper limb use. Patients mark their responses on a 10 cm visual analogue scale, with scores ranging up to 50 for pain, 80 for disability, and a total of 130, all expressed as percentages. SPADI has demonstrated strong validity and reliability, including in its Arabic version, with an intra-rater reliability coefficient of 0.89, making it a dependable tool for clinical and research use.

    4 weeks

Study Arms (3)

Group (GI)= 15 will be treated by Radiofrequency TECAR Therapy

EXPERIMENTAL

Group (GI) will be treated by Radiofrequency TECAR Therapy on shoulder joint as well as Designed Physical Therapy Program

Device: Radiofrequency

Group (GII)= 15 will be treated by Ultrasound Therapy

EXPERIMENTAL

Group (GII) will be treated by Ultrasound Therapy on shoulder joint as well as Designed Physical Therapy Program

Device: Ultrasound

Group (GIII)= 15 will be treated by Designed Physical Therapy Program,

EXPERIMENTAL

Group (GIII) will be treated by Designed Physical Therapy Program, all outcomes' measures will be assessed pre and post treatment.

Other: The designed physical therapy program

Interventions

Radiofrequency (TECAR) therapy is a non-invasive, non-ablative treatment that uses electromagnetic energy to generate endogenous heat, promoting increased blood flow and tissue healing in both superficial and deep tissues. With a long wavelength and low frequency (300 KHz to 1 MHz), it can penetrate deeply into muscles, tendons, and bones, making it suitable even in acute conditions. TECAR operates in two modes: capacitive (targeting soft tissues rich in electrolytes) and resistive (targeting high-resistance tissues like bones and tendons). The therapy stimulates natural repair processes by inducing ion flow and micro-hyperemia, leading to the release of endorphins and cortisone, which help reduce pain, inflammation, and edema, while enhancing immune response and tissue regeneration.

Group (GI)= 15 will be treated by Radiofrequency TECAR Therapy

The ultrasound waves accelerate healing, increasing local vascularity and improving several other characteristics, including energy absorption capacity and maximum rupture resistance tension, increased collagen synthesis, fibroblast proliferation, release of growth factors stimulated by mast cell degranulation and improved response of platelets and macrophages anticipating the proliferative and remodeling phase. 1-MHz continuous ultrasound, with a half-value depth of approximately 2.3 cm, is frequently used to treat deep tissues that are approximately 2.3 to 5 cm deep.

Also known as: US
Group (GII)= 15 will be treated by Ultrasound Therapy

The designed physical therapy program focuses on improving upper limb mobility and stability through a structured set of exercises targeting the shoulder joint. It includes prolonged stretching performed in a seated position to extend the thumb, fingers, wrist, elbow, and shoulder, along with scapular mobilization in side-lying and stretching of internal rotators in a supine position. The stretching progression begins with external rotation at 45° abduction and advances to 90° abduction and full reach toward the ground if pain-free. Joint stabilization exercises involve resistance band movements in various shoulder and elbow positions, including controlled abduction, flexion, scapular movements, and external rotation, all aimed at enhancing joint control and muscular coordination.

Also known as: Treatment Exercises
Group (GIII)= 15 will be treated by Designed Physical Therapy Program,

Eligibility Criteria

Age30 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Fourty-five hemiplegic patients with shoulder pain post- stroke from both sexes will participate in this study.
  • The patients will be older than 18 years old (30-60 years old)
  • The presence of sub-acute shoulder pain (more than 3 months).
  • Sub-acute stroke survivors (3 months post-stroke).
  • score of 1\|1+ points on the Modified Ashworth Scale (MAS) on shoulder joint.
  • Stage 2 or above according to Brunnstrom function assessment of shoulder joint
  • All conducted patients experienced a single stroke during the last 3 months with cognitive capacity that will enable them to comprehend and follow the instructions (Mini-Mental Scale score \> 24).

You may not qualify if:

  • The following patients will be excluded from the study patients with:
  • Bilateral adhesive capsulitis
  • Systemic diseases such as rheumatoid arthritis, malignancies, heart diseases, infections, coagulation disorders, full rotator cuff tears
  • A history of recent shoulder surgery, neurological problems involving the upper extremity, shoulder joint osteoarthritis
  • Upper extremity fractures, cervical radiculopathy
  • Impaired sensation, having a heart pacemaker, pregnancy
  • Injuries in the upper limbs
  • Other neurological diseases or cancer
  • Osteosynthesis material or pacemaker
  • Botulinum toxin or antispastic treatment 3 months prior to studying.
  • Any contraindication to massage and Tecar as skin infections, inflammatory vascular diseases, or acute inflammation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Physical Therapy Delta University

Gamasa, Egypt

RECRUITING

MeSH Terms

Conditions

StrokeHemiplegiaShoulder Pain

Interventions

Ultrasonography

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesParalysisNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsArthralgiaJoint DiseasesMusculoskeletal DiseasesPain

Intervention Hierarchy (Ancestors)

Diagnostic ImagingDiagnostic Techniques and ProceduresDiagnosis

Central Study Contacts

Muhammed E Abulftouh

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Fourty-five hemiplegic patients with shoulder pain post- stroke from both sexes will participate in this study. * The patients will be older than 18 years old (30-60 years old) * The presence of sub-acute shoulder pain (more than 3 months). * Sub-acute stroke survivors (3 months post-stroke). * score of 1\|1+ points on the Modified Ashworth Scale (MAS) on shoulder joint. * Stage 2 or above according to Brunnstrom function assessment of shoulder joint * All conducted patients experienced a single stroke during the last 3 months with cognitive capacity that will enable them to comprehend and follow the instructions (Mini-Mental Scale score \> 24). Therapeutic Equipment and tools TECAR (Transfer Electrical Capacitive and Resistive) therapy and ultrasound therapy are advanced non-invasive therapeutic modalities used in physiotherapy to accelerate tissue healing and pain relief. TECAR therapy utilizes radiofrequency energy to generate deep endogenous heat, enhancing blood flow.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Demonestrator for Physical Therapy for Neurology and Its Surgery

Study Record Dates

First Submitted

August 13, 2025

First Posted

August 20, 2025

Study Start

September 28, 2025

Primary Completion

November 12, 2025

Study Completion

November 12, 2025

Last Updated

October 2, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations